Table 2: Neonatal outcomes in the two study groups.

INSURE/NCPAP (n.31)INSURE/SNIPPV (n.33) value

INSURE failure11 (35.5)2 (6.1)0.004
Pneumothorax1 (3.2)00.484
Surfactant second dose7 (22.6)1 (3.0)0.025
Caffeine high maintenance dose9 (29.0)3 (9.9)0.041
PDA treated8 (25.8)2 (6.1)0.041
Postnatal steroids4 (12.9)1 (3.0)0.190
O2 dep. at 28 days6 (19.3)1 (3.0)0.050
O2 dep. at 36 weeks PMA4 (12.9)00.050
Late onset sepsis4 (12.9)4 (12.1)1.000
Feeding intolerance 3 (9.7)4 (12.1)1.000
NEC1 (3.2)00.484
IVH (1-2°)2 (6.4)2 (6.0)1.000
IVH (3-4°)1 (3.2)1 (3.0)1.000
PVL001.000
ROP01 (3.0)1.000
Death001.000

Values are given as number and (%).